Intuitive Surgical (ISRG) shares fell after the company reported earnings, despite a 22% jump in revenue. The article argues the real revenue driver is not da Vinci robot sales, which account for roughly 25% of revenue, but instruments, accessories, and services. Although Medtronic and Johnson & Johnson have entered surgical robotics, Intuitive sold more da Vinci systems in Q3 2026 than in Q3 2025, and procedures rose 15% while installed systems grew 12% year over year. With more than 12,000 installed systems generating recurring income, the article says the company still has room to grow as surgical robotics is far from saturation.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
Intuitive Surgicalhealthcareearnings
Open a keyword to see other news on the same topic.
Related news
- Intuitive Announces Third Quarter Earnings
Intuitive reported that worldwide procedures using da Vinci and Ion systems grew about 15% in the third quarter of 2026. Revenue rose 22% to $3.05 billion from $2.51 billion, and the company placed 546 da Vinci systems versus 427 a year earlier. GAAP net income fell to $523 million, or $1.49 per diluted share, from $704 million, reflecting a $450 million pre-tax charge to settle antitrust class action litigation. Non-GAAP net income rose to $1.05 billion, or $3.00 per diluted share, from $867 million, and the company repurchased 7.8 million shares for $2.94 billion during the quarter.
- Intuitive Surgical (ISRG) Stock Is Down 25% Year to Date. History Says Patient Investors Get Rewarded.
Intuitive Surgical has installed over 11,700 robotic surgical systems in more than 70 countries, generally at over $1 million each, and its market value is nearly $150 billion. In the second quarter it placed 468 da Vinci systems, up from 395, lifting its installed base 12% year over year, while revenue rose 19% to $2.9 billion. The stock slid 26% in 2022, gained 27% in 2023 and 55% in 2024. It pays no dividend, but including buybacks its total yield was about 2.4%, and its forward P/E of 35 sits below the five-year average of 52. The article flags rising competition, weight-loss drugs pressuring robotic bariatric surgeries, and cooling growth as risks.
- 3 Wall Street Analysts See Intuitive Surgical Hitting $500. Here's the Bull Case.
Three Wall Street analysts at Oppenheimer, Citigroup and Baird see Intuitive Surgical (ISRG) reaching $500 per share. Oppenheimer upgraded the stock to Outperform in August with a $500 target, while Citigroup and Baird cut their targets to $500 in July but kept Buy and Outperform ratings. The article cites growth from recurring revenue: in the second quarter of 2026 the company placed 246 da Vinci 5 systems versus 180 a year earlier, procedures rose 15%, and instrument and accessory revenue climbed 18% to roughly $1.7 billion. Key risks include slower procedure growth, tight hospital budgets and rising competition, and the stock's P/E of about 49 leaves little room for disappointment. A consensus of 31 analysts rates it Strong Buy, with targets implying 12% to 60% upside, and third-quarter results are expected around Oct. 20.
- MakeMyTrip Shares Rise 4.8% as Q2 Profit Improves Despite Revenue Missing Estimates
MakeMyTrip (NASDAQ: MMYT) reported second-quarter fiscal 2027 adjusted EPS of $0.47, in line with analyst estimates, but revenue of $235.2 million, up 2.5% year on year, fell short of the $267.4 million expected. On a constant currency basis, revenue rose 11.2%; the company said the Indian rupee depreciated about 10% against the US dollar during the quarter. Demand for international long-haul outbound travel from India weakened due to higher travel costs from elevated fuel prices and the weaker rupee, while domestic travel demand grew strongly and partly offset the decline. Adjusted net profit before tax rose 27% to $46.2 million, and gross bookings reached $2.72 billion, up 11.3% (20.9% at constant currency). Adjusted margin for hotels and packages reached $116.8 million, up 10.4%, supported by an 18.5% increase in hotel room nights booked.
- JPMorgan Chase Raises Full-Year Net Interest Income Outlook Despite Missing Q3 Revenue Expectations
JPMorgan Chase (JPM) reported third-quarter earnings of $5.57 per share, below the $5.91 estimate and its first miss in almost three years. Revenue reached $50.9 billion, up 8% from a year earlier, and net income was $15.3 billion, though results included a $658 million loss on investment securities. Investment banking fees rose 14% year over year but fell 8% from the second quarter, as rate uncertainty, high energy prices and geopolitical tensions kept many deals on the sidelines. The bank raised its full-year net interest income forecast to about $106.2 billion from $105.5 billion and its expense forecast to about $108.6 billion from $107.5 billion. CFO Jeremy Barnum said the investment banking pipeline remains very strong, while JPM shares were up 0.3% in volatile early trading.
- Should You Buy Vistra After an 11% 1-Day Jump on a $4.2 Billion DOE Loan? The Catch Most Investors Are Missing.
On Oct. 5, 2026, the U.S. Department of Energy announced a conditional loan commitment of up to $4.2 billion to modernize three Vistra nuclear plants in Ohio and Pennsylvania, aiming to add 433 megawatts of capacity and extend their operating lives by 20 years. Vistra shares jumped 11% in a single day on the news. Ongoing Operations Adjusted EBITDA for Q2 2026 rose more than 30% year over year to around $1.8 billion, driven mainly by higher energy and capacity prices and acquired plants. The article stresses that the DOE package is financing, not a grant, so Vistra must meet technical, legal, environmental and financial requirements and repay the loan, and delays or cost overruns could push back payoff. The stock trades at a P/E of about 26, and 18 analysts rate it a Strong Buy.
Related markets
Latest news
- MPLX Reports Earnings on Nov. 3, 2026. Here's What Investors Should Be Watching.
MPLX will report third-quarter results on Tuesday, Nov. 3, after management said the third quarter should be stronger than the second, and the fourth stronger still. The MLP spent $5.5 billion on growth projects and acquisitions last year and plans $2.9 billion in growth capex in 2026, aiming for mid-single-digit adjusted EBITDA growth. First-half adjusted EBITDA reached $3.5 billion, up less than 2% year over year, so the second half must accelerate. The article estimates third-quarter adjusted EBITDA near $1.85 billion, versus nearly $1.8 billion in the second quarter. The board declared a third-quarter distribution of $1.2111 per unit, up 12.5% year over year, making distribution coverage (1.3x at the end of the second quarter) and leverage (3.7x, versus a 4.0x target) key metrics to watch.
- Learn Why The Bull Case For JPMorgan Chase Stock Could Change Following Earnings Miss
JPMorgan Chase reported third-quarter earnings below expectations for the first time since 2023, while raising its 2026 net interest income outlook to about US$106.2 billion. The bank is cutting share buybacks and raising its dividend, directing capital toward technology, AI and franchise investment and accepting higher noninterest expenses rather than maximizing near-term payouts. It is also issuing multiple callable senior unsecured notes maturing between 2031 and 2056, with coupons mostly in the 5.5% to 6.7% range, signaling a focus on balance sheet flexibility and long-dated funding. The article notes that a weaker credit or capital markets environment combined with elevated spending could squeeze margins and returns. Consensus figures project revenue of US$227.1 billion and earnings of US$68.8 billion by 2029, based on an assumed 6.8% annual revenue growth rate, an increase of about US$5.2 billion from current earnings of US$63.6 billion.
- Barclays Says a SpaceX Merger Is Now "a Key Part" of the Tesla Bull Case. Here's Who Actually Wins if It Happens -- and Who Pays.
On Space Exploration Technologies' (SPCX) third-quarter conference call, CEO Elon Musk said he thought a merger with Tesla was a good idea, and the two companies have each formed a special committee to explore a combination. Barclays says such a deal would likely be funded largely or entirely through stock, and Tesla shareholders could benefit given SpaceX's market capitalization of roughly $2 trillion compared with roughly $1.55 trillion for Tesla. Barclays upgraded Tesla from equal weight to overweight and raised its one-year price target from $370 to $450 per share, a level that matches its expected all-stock buyout value, a premium of roughly 20% over the current price, or about 3.1 SpaceX shares per Tesla share. The deal would need a 50% affirmative vote from Tesla shareholders, with investors who do not vote counted as "no" votes, and Musk controls about 20% of voting power but would still likely need meaningful retail investor support. The article also notes that heavy dilution from new SpaceX share issuance to fund a deal makes the post-deal outlook for SpaceX stock harder to predict.
- Centerra Gold Inc (CGAU) (Q3 2026) Earnings Call Highlights: Record Buybacks, Lower Mount ...
Centerra Gold reported third-quarter adjusted net earnings of $72 million, or $0.37 per share, with operating cash flow of $143 million and free cash flow of $17 million. The company bought back a record $53 million of shares in the quarter, bringing year-to-date repurchases to $125 million, and declared a quarterly dividend of $0.07 per share. Mount Milligan's third-quarter all-in sustaining cost on a byproduct basis was $985 per ounce, and full-year guidance was lowered to $1,100–$1,200 per ounce from $1,200–$1,300, supported by copper by-product credits. The Thompson Creek restart is about 75% complete with first molybdenum production expected in mid-2027, though molybdenum prices cannot be hedged and Mount Milligan costs are tracking about 5% above budget. Cash fell roughly $50 million in the quarter, and the company plans to hold only $100–$200 million in cash, with total liquidity of $998 million.
- Prediction: Nvidia Stock Is Going to Soar After Nov. 17
Nvidia's market capitalization tops $5 trillion, and its stock is up nearly 15% in 2026. Revenue in the fiscal 2027 second quarter reached $96.2 billion, up 106% year over year, with a 75% non-GAAP gross margin. The company forecasts about $108 billion in third-quarter revenue, while analysts expect about $109 billion. CEO Jensen Huang sees global AI infrastructure spending reaching $3 trillion to $4 trillion by 2030, and the Vera Rubin platform could generate $40 billion per gigawatt, 60% more than Blackwell. Nvidia trades at about 23 times forward earnings versus 18.6 for the S&P 500, which the author considers reasonable given its growth; the company reports on Nov. 17.
- BWX Technologies Reports Earnings on Nov. 2 2026. Here's What Investors Should Be Watching.
BWX Technologies (BWXT) will report fiscal 2026 third-quarter results after market close. The company builds nuclear reactors and components for U.S. Navy submarines and aircraft carriers, and is the sole nuclear fuel provider to the Navy, while also serving the commercial nuclear energy market. Although the shares are down 40% over six months, the article says the drop is not due to weak operations: management raised its fiscal 2026 revenue forecast to about $3.8 billion, and backlog stood at $8.4 billion as of June 30. The stock fell from an April 52-week high of $241.82 to a 52-week low of $123.05, mainly amid a broader sell-off in defense stocks over midterm election concerns and in nuclear stocks over worries about AI data center spending. Management expects nearly 55% of second-half earnings to come in the fourth quarter and targets $5.5 billion to $6 billion in revenue by 2030, and the article says the long-term thesis has not changed.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.